RT Journal Article
SR Electronic
T1 Management of hyperlipidaemia
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 89
OP 92
DO 10.1136/dtb.25.23.89
VO 25
IS 23
YR 1987
UL http://dtb.bmj.com/content/25/23/89.abstract
AB Hyperlipidaemia, together with smoking, hypertension and insufficient physical exercise, is now recognised as an important risk factor for coronary heart disease (CHD). Lowering high plasma cholesterol levels reduces the risk of developing CHD1,2 and can slow its progression3,4. A health education programme to reduce our very high incidence of CHD by altering lifestyle and diet is being encouraged5,6. It needs to be combined with screening for, and modifying, individual risk factors. This article discusses such a strategy for hyperlipidaemia.